Date | Company Name | Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|---|
Nov 29, 2022 | Cajal Neuroscience | Series A | — | Biotechnology | Yes |
Jan 6, 2022 | Eikon Therapeutics | Series B | — | Biotechnology | — |
May 5, 2021 | Eikon Therapeutics | Series A | — | Biotechnology | Yes |
Mar 1, 2021 | Tenaya Therapeutics | Series C | — | Biopharma | — |
Oct 6, 2020 | A2 Biotherapeutics | Series B | — | Biotechnology | — |
Nov 5, 2019 | A2 Biotherapeutics | Series A | — | Biotechnology | — |
Oct 3, 2019 | Tenaya Therapeutics | Series B | — | Biopharma | — |
Aug 9, 2019 | ORIC Pharmaceuticals | Series D | — | Biotechnology | — |
Jun 19, 2019 | Rapt Therapeutics | Series C | — | Biotechnology | — |
Feb 21, 2018 | ORIC Pharmaceuticals | Series C | — | Biotechnology | — |
Dec 21, 2017 | Rapt Therapeutics | Series C | — | Biotechnology | — |
Nov 13, 2017 | Arcus Biosciences | Series C | — | Biotechnology | — |
Dec 6, 2016 | Tenaya Therapeutics | Series A | — | Biopharma | Yes |
Sep 1, 2016 | Arcus Biosciences | Series B | — | Biotechnology | — |
Apr 26, 2016 | Rapt Therapeutics | Series B | — | Biotechnology | — |
Dec 2, 2015 | ORIC Pharmaceuticals | Series B | — | Biotechnology | Yes |
May 1, 2015 | Arcus Biosciences | Series A | — | Biotechnology | — |
Nov 1, 2014 | ORIC Pharmaceuticals | Series A | — | Biotechnology | Yes |